It will be interesting to determine whether mammary-enriched ELF5, STAT5, NFIB, and GR are also recruited in these super-enhancers and whether differential molecular recruitment to super-enhancers determines the different breast cancer subtypes. The gene discussed is NR3C1; the disease is breast cancer.